Sign In
Buy AVNS
$24.98
-0.0150 (-0.0600%)
At Close: Jun 03, 2026
Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2019 Results - Earnings Call Transcript
08:00pm, Tuesday, 25'th Feb 2020
Avanos Medical, Inc. (NYSE:AVNS) Q4 2019 Earnings Conference Call February 25, 2020 09:00 AM ET Company Participants Dave Crawford - Vice President of Investor
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates
02:05pm, Tuesday, 25'th Feb 2020
Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates
02:05pm, Tuesday, 25'th Feb 2020
Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
01:28pm, Tuesday, 25'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst
Avanos Medical: 4Q Earnings Snapshot
01:13pm, Tuesday, 25'th Feb 2020
ALPHARETTA, Ga. (AP) _ Avanos Medical, Inc. (AVNS) on Tuesday reported a loss of $6.1 million in its fourth quarter.
The Alpharetta, Georgia-based company said it had a loss of 13 cents per share. Ear
Avanos Medical, Inc. to Host Earnings Call
12:00pm, Tuesday, 25'th Feb 2020
NEW YORK, NY / ACCESSWIRE / February 25, 2020 / Avanos Medical, Inc. (NYSE:AVNS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on February 25, 2020 at
Investors Who Bought Avanos Medical (NYSE:AVNS) Shares A Year Ago Are Now Down 39%
10:25am, Tuesday, 25'th Feb 2020
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...
BRIEF-Avanos Medical Announces FDA Clearance Of 80-Watt Coolief Radiofrequency System For Neurological Lesion Procedures
10:06pm, Monday, 24'th Feb 2020
Avanos Medical Inc:
Avanos Medical, Inc. (NYSE: AVNS) today announced the U.S. Food and Drug Administration (FDA) has cleared for marketing its new, 80-Watt COOLIEF* Radiofrequency (RF) system for neurological lesion pro
Avanos Medical, Inc. to Present at Two Investor Conferences in March
12:00pm, Monday, 24'th Feb 2020
Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two investor conferences in March:
Avanos Medical (AVNS) to Release Earnings on Tuesday
08:56am, Monday, 24'th Feb 2020
Avanos Medical (NYSE:AVNS) is scheduled to be releasing its earnings data before the market opens on Tuesday, February 25th. Analysts expect Avanos Medical to post earnings of $0.32 per share for the
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
$177.83 Million in Sales Expected for Avanos Medical Inc (NYSE:AVNS) This Quarter
03:10pm, Sunday, 16'th Feb 2020
Analysts predict that Avanos Medical Inc (NYSE:AVNS) will report $177.83 million in sales for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Avanos Medical’
Avanos Medical Inc (NYSE:AVNS) Expected to Post Earnings of $0.32 Per Share
03:08pm, Sunday, 16'th Feb 2020
Brokerages expect Avanos Medical Inc (NYSE:AVNS) to post earnings per share of $0.32 for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for
Avanos Medical Inc (NYSE:AVNS) Shares Sold by North Star Asset Management Inc.
09:30pm, Friday, 14'th Feb 2020
North Star Asset Management Inc. reduced its position in Avanos Medical Inc (NYSE:AVNS) by 2.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 27,131 shares of the comp
